End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
19.6
CNY
|
+4.26%
|
|
+4.59%
|
-11.15%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
8,030
|
14,640
|
18,410
|
19,474
|
22,154
|
19,682
|
-
|
Enterprise Value (EV)
1 |
8,030
|
14,640
|
18,410
|
19,474
|
22,154
|
17,638
|
17,311
|
P/E ratio
|
17.3
x
|
26
x
|
26.6
x
|
27.7
x
|
26.6
x
|
19.3
x
|
16
x
|
Yield
|
3.02%
|
-
|
1.61%
|
1.55%
|
1.5%
|
2.08%
|
2.49%
|
Capitalization / Revenue
|
2.92
x
|
4.28
x
|
4.8
x
|
5.92
x
|
5.53
x
|
4.08
x
|
3.43
x
|
EV / Revenue
|
2.92
x
|
4.28
x
|
4.8
x
|
5.92
x
|
5.53
x
|
3.66
x
|
3.02
x
|
EV / EBITDA
|
11
x
|
15.8
x
|
16.4
x
|
-
|
16.9
x
|
11.6
x
|
9.54
x
|
EV / FCF
|
-
|
-
|
33
x
|
-
|
-
|
35.1
x
|
23.5
x
|
FCF Yield
|
-
|
-
|
3.03%
|
-
|
-
|
2.85%
|
4.25%
|
Price to Book
|
1.71
x
|
2.9
x
|
3.36
x
|
3.28
x
|
3.39
x
|
2.74
x
|
2.46
x
|
Nbr of stocks (in thousands)
|
969,817
|
988,526
|
989,235
|
1,004,848
|
1,004,253
|
1,004,181
|
-
|
Reference price
2 |
8.280
|
14.81
|
18.61
|
19.38
|
22.06
|
19.60
|
19.60
|
Announcement Date
|
1/7/20
|
1/9/21
|
1/14/22
|
1/10/23
|
1/17/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
2,755
|
3,418
|
3,835
|
3,291
|
4,007
|
4,822
|
5,734
|
EBITDA
1 |
728.6
|
925.3
|
1,121
|
-
|
1,312
|
1,526
|
1,814
|
EBIT
1 |
549.3
|
673.5
|
840.2
|
828
|
972.4
|
1,200
|
1,414
|
Operating Margin
|
19.94%
|
19.7%
|
21.91%
|
25.16%
|
24.27%
|
24.89%
|
24.66%
|
Earnings before Tax (EBT)
1 |
550.7
|
671.5
|
843
|
823.7
|
971.8
|
1,208
|
1,422
|
Net income
1 |
466.9
|
558.4
|
691.7
|
689.1
|
825.2
|
1,018
|
1,227
|
Net margin
|
16.95%
|
16.34%
|
18.04%
|
20.94%
|
20.6%
|
21.12%
|
21.4%
|
EPS
2 |
0.4800
|
0.5700
|
0.7000
|
0.7000
|
0.8300
|
1.016
|
1.223
|
Free Cash Flow
1 |
-
|
-
|
557.1
|
-
|
-
|
502
|
736
|
FCF margin
|
-
|
-
|
14.53%
|
-
|
-
|
10.41%
|
12.84%
|
FCF Conversion (EBITDA)
|
-
|
-
|
49.72%
|
-
|
-
|
32.91%
|
40.57%
|
FCF Conversion (Net income)
|
-
|
-
|
80.54%
|
-
|
-
|
49.29%
|
59.98%
|
Dividend per Share
2 |
0.2500
|
-
|
0.3000
|
0.3000
|
0.3300
|
0.4075
|
0.4880
|
Announcement Date
|
1/7/20
|
1/9/21
|
1/14/22
|
1/10/23
|
1/17/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
2,044
|
2,371
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
557
|
-
|
-
|
502
|
736
|
ROE (net income / shareholders' equity)
|
10.3%
|
11.6%
|
13.6%
|
12.4%
|
13.6%
|
14.9%
|
16.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
11%
|
11.9%
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
9,301
|
10,311
|
Book Value Per Share
2 |
4.840
|
5.100
|
5.540
|
5.920
|
6.510
|
7.160
|
7.970
|
Cash Flow per Share
2 |
0.6700
|
0.7200
|
0.7200
|
-
|
0.8600
|
1.380
|
1.520
|
Capex
1 |
436
|
338
|
152
|
-
|
497
|
880
|
920
|
Capex / Sales
|
15.81%
|
9.88%
|
3.96%
|
-
|
12.41%
|
18.25%
|
16.04%
|
Announcement Date
|
1/7/20
|
1/9/21
|
1/14/22
|
1/10/23
|
1/17/24
|
-
|
-
|
Last Close Price
19.6
CNY Average target price
23.35
CNY Spread / Average Target +19.13% Consensus |
1st Jan change
|
Capi.
|
---|
| -11.15% | 2.72B | | 0.00% | 6.8B | | -12.39% | 2.88B | | -31.21% | 1.74B | | +5.00% | 1.25B | | -7.31% | 1.06B | | -6.67% | 870M | | -4.08% | 794M | | -13.72% | 768M | | +0.62% | 757M |
Testing Laboratories
|